Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475561![]() (1-[6-Chloro-5-(4-chloro-phenylmethanesulfonyl)-1H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475561![]() (1-[6-Chloro-5-(4-chloro-phenylmethanesulfonyl)-1H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475479![]() (1-[6-Chloro-5-(4-methoxy-phenylmethanesulfonyl)-1H...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475563![]() (1-(6-Chloro-5-cyclohexylmethanesulfonyl-1H- | US10...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475557![]() (1-[6-Chloro-5-(4-methyl-benzylsulfanyl)-1H- | US10...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475567![]() (1-[6-Chloro-5-(4-trifluoromethyl-phenylmethanesulf...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475479![]() (1-[6-Chloro-5-(4-methoxy-phenylmethanesulfonyl)-1H...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475563![]() (1-(6-Chloro-5-cyclohexylmethanesulfonyl-1H- | US10...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475557![]() (1-[6-Chloro-5-(4-methyl-benzylsulfanyl)-1H- | US10...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475567![]() (1-[6-Chloro-5-(4-trifluoromethyl-phenylmethanesulf...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475569![]() (1-[6-Chloro-5-(2'-cyano-biphenyl-4-ylmethanesulfon...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475569![]() (1-[6-Chloro-5-(2'-cyano-biphenyl-4-ylmethanesulfon...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475485![]() (1-(6-Methanesulfonyl-5-trifluoromethyl-1H- | US108...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475543![]() (1-(5-Ethylsulfonyl-6-trifluoromethoxy-1H-benzoimid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475550![]() (1-[5-(4-Methoxy-benzenesulfonyl)-6-trifluoromethyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475562![]() (1-[6-Chloro-5-(3-chloro-phenylmethanesulfonyl)-1H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475564![]() (1-[6-Chloro-5-(3,4-dichloro-phenylmethanesulfonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475568![]() (1-[5-(2,4-Bis-trifluoromethyl-phenylmethanesulfony...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475542![]() (1-(5-Ethylsulfonyl-6-trifluoromethyl-1H-benzoimida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475543![]() (1-(5-Ethylsulfonyl-6-trifluoromethoxy-1H-benzoimid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475549![]() (1-(5-Benzenesulfonyl-6-trifluoromethyl-1H- | US108...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475550![]() (1-[5-(4-Methoxy-benzenesulfonyl)-6-trifluoromethyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475562![]() (1-[6-Chloro-5-(3-chloro-phenylmethanesulfonyl)-1H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475564![]() (1-[6-Chloro-5-(3,4-dichloro-phenylmethanesulfonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475568![]() (1-[5-(2,4-Bis-trifluoromethyl-phenylmethanesulfony...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475401![]() (1-{5-[3-(2-Chloro-benzyloxy)-phenyl]-1H-benzoimida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475401![]() (1-{5-[3-(2-Chloro-benzyloxy)-phenyl]-1H-benzoimida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475485![]() (1-(6-Methanesulfonyl-5-trifluoromethyl-1H- | US108...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475542![]() (1-(5-Ethylsulfonyl-6-trifluoromethyl-1H-benzoimida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475549![]() (1-(5-Benzenesulfonyl-6-trifluoromethyl-1H- | US108...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475471![]() (1-(5-Benzenesulfonyl-6-chloro-1H-benzoimidazol-2-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 26.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475471![]() (1-(5-Benzenesulfonyl-6-chloro-1H-benzoimidazol-2-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 26.9 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475477![]() (1-(6-Chloro-5-phenylmethanesulfonyl-1H- | US108510...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475494![]() (1-[6-(Propane-1-sulfonyl)-5-trifluoromethoxy-1H- |...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475481![]() (1-[6-Chloro-5-(2-chloro-phenylmethanesulfonyl)-1H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475488![]() (1-(6-Methanesulfonyl-5-trifluoromethoxy-1H- | US10...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475490![]() (1-[5-Chloro-6-(propane-1-sulfonyl)-1H-benzoimidazo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475492![]() (1-[6-(Propane-1-sulfonyl)-5-trifluoromethyl-1H- | ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475494![]() (1-[6-(Propane-1-sulfonyl)-5-trifluoromethoxy-1H- |...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475548![]() (1-[5-(4-Methoxy-phenylsulfanyl)-6-trifluoromethyl-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475560![]() (1-[6-Chloro-5-(2'-cyano-biphenyl-4-ylmethylsulfany...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475565![]() (1-[6-Chloro-5-(2,6-dichloro-phenylmethanesulfonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475548![]() (1-[5-(4-Methoxy-phenylsulfanyl)-6-trifluoromethyl-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475560![]() (1-[6-Chloro-5-(2'-cyano-biphenyl-4-ylmethylsulfany...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475565![]() (1-[6-Chloro-5-(2,6-dichloro-phenylmethanesulfonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475400![]() (1-{5-[3-(3-Chloro-benzyloxy)-phenyl]-1H-benzoimida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475428![]() (1-(6-Chloro-5-nitro-1H-benzoimidazol-2-yl)-1H-pyra...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475443![]() (1-[5-(4-Chloro-phenoxy)-6-trifluoromethyl-1H- | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The PHD2 181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypep... | Citation and Details BindingDB Entry DOI: 10.7270/Q2V69PHV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475400![]() (1-{5-[3-(3-Chloro-benzyloxy)-phenyl]-1H-benzoimida...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 [181-417] (Homo sapiens (Human)) | BDBM475428![]() (1-(6-Chloro-5-nitro-1H-benzoimidazol-2-yl)-1H-pyra...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 31.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description The PHD2181-417 polypeptide (3 μg) was pre-incubated for 30 minutes with test compound prior to assessing the enzymatic activity of the polypept... | US Patent US10851083 (2020) BindingDB Entry DOI: 10.7270/Q25B05K9 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 388 total ) | Next | Last >> |